Providence Wealth Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.62M | Buy |
14,740
+239
| +2% | +$26.2K | 1.11% | 32 |
|
|
2025
Q1 | $1.61M | Buy |
14,501
+34
| +0.2% | +$3.77K | 1.22% | 30 |
|
|
2024
Q4 | $1.32M | Sell |
14,467
-55
| -0.4% | -$5.01K | 1% | 33 |
|
|
2024
Q3 | $1.28M | Buy |
14,522
+425
| +3% | +$37.3K | 0.94% | 35 |
|
|
2024
Q2 | $981K | Buy |
14,097
+709
| +5% | +$49.3K | 0.78% | 42 |
|
|
2024
Q1 | $964K | Sell |
13,388
-8,674
| -39% | -$625K | 0.82% | 42 |
|
|
2023
Q4 | $4.28M | Buy |
22,062
+9,921
| +82% | +$1.93M | 3.87% | 4 |
|
|
2023
Q3 | $892K | Buy |
12,141
+141
| +1% | +$10.4K | 1% | 35 |
|
|
2023
Q2 | $927K | Buy |
12,000
+460
| +4% | +$35.5K | 1.03% | 32 |
|
|
2023
Q1 | $970K | Sell |
11,540
-1,190
| -9% | -$100K | 0.72% | 43 |
|
|
2022
Q4 | $1.09M | Buy |
12,730
+217
| +2% | +$18.6K | 0.81% | 41 |
|
|
2022
Q3 | $1.04M | Sell |
12,513
-10
| -0.1% | -$830 | 0.78% | 42 |
|
|
2022
Q2 | $780K | Buy |
12,523
+1,270
| +11% | +$79.1K | 0.56% | 55 |
|
|
2022
Q1 | $671K | Buy |
11,253
+338
| +3% | +$20.2K | 0.43% | 65 |
|
|
2021
Q4 | $786K | Buy |
10,915
+1,405
| +15% | +$101K | 0.49% | 57 |
|
|
2021
Q3 | $651K | Buy |
+9,510
| New | +$651K | 0.45% | 64 |
|